Avanos MedicalAVNS +0.20%62 Days Payable is 55.89 as of Mar. 2026, which is 30% below its 10-year median of 79.56. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.42 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Avanos Medical ranks worse than 64.65% on this metric.
The historical rank and industry rank for Avanos Medical's Days Payable or its related term are showing as below:
AVNS'
s Days Payable Range Over the Past 10 Years
Min: 52.42 Med: 79.56 Max: 238.14
Current: 52.42
During the past 13 years, Avanos Medical's highest Days Payable was 238.14. The lowest was 52.42. And the median was 79.56.
AVNS's Days Payable is ranked worse than 64.65% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs AVNS: 52.42
Avanos Medical's Days Payable
declined
from Mar. 2025 (58.90) to Mar. 2026 (55.89).
It may suggest that Avanos Medicalaccelerated paying its suppliers.
Avanos Medical Days Payable Related Terms
Avanos Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Avanos Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Avanos Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Avanos Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a Days Payable of 55.89 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avanos Medical and its competitors. This is 30% below median its historical median of 79.56. Over the past decade, Avanos Medical's Days Payable has ranged from 52.42 to 238.14. According to the industry distribution chart, Avanos Medical ranks #514 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 64.7%.
Is Avanos Medical's Days Payable too high?
Avanos Medical's current Days Payable of 55.89 is 30% below median its 10-year median of 79.56. Over the past 10 years, this metric has ranged from a low of 52.42 to a high of 238.14. The Medical Devices & Instruments industry median Days Payable is 67.87. Avanos Medical's value of 55.89 is 17.7% below this industry median. Based on the distribution chart, Avanos Medical ranks #514 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Days Payable compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #514 out of 795 companies for Days Payable. This places Avanos Medical in the lower half of its industry. The industry median Days Payable is 67.87. Avanos Medical's value of 55.89 is 17.7% below this benchmark. Historically, Avanos Medical's own Days Payable has ranged from 52.42 to 238.14 over the past decade. While the company's 10-year median is 79.56 vs. the industry median of 67.87, Avanos Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current Days Payable of 55.89 is 17.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current Days Payable is 55.89, which is 30% below median its own 10-year median of 79.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.42, compared to a current price of $24.95 — trading 28.5% above its estimated fair value. The current Days Payable is 55.89, which is 30% below median its 10-year median of 79.56 and 17.7% below the Medical Devices & Instruments industry median of 67.87. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Days Payable is 55.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.5% above its estimated GF Value™ of $19.42.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
Days Payable: 55.89 (30% below median its 10-year median of 79.56)
GF Value™: $19.42 vs. price of $24.95 (28.5% above fair value)
Industry Position: 17.7% below the Medical Devices & Instruments median (#514 of 795)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
